SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that the California Technology Assessment Forum completed an independent evaluation of the cell-free fetal DNA technology used in the Sequenom Center for Molecular Medicine’s (Sequenom CMM) MaterniT21 PLUS™ laboratory-developed test (LDT). CTAF recommended that […]
ITHACA, N.Y. – Rheonix Inc., developer of automated molecular diagnostic platforms and consumables, has appointed Bill Colston, Ph.D., to its board of directors. Colston, former CEO of QuantaLife Inc., led the development and product launch of Droplet Digital PCR™, a genetic analysis system for quantifying DNA molecules, until his company was acquired by Bio-Rad Laboratories […]
Washington, D.C., – Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it has extended the tender offer, through its wholly owned subsidiary Daphne Acquisition Corporation, for all outstanding shares of common stock of IRIS International, Inc. (NASDAQ: IRIS) (“IRIS”) to 12:00 midnight, New York City time, on October 29, 2012, unless further extended. The tender […]
SAN DIEGO and ST. LOUIS, — Assay Depot and Rare Genomics Institute have joined together in a unique partnership with 19 life science companies to launch the first Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries). Rare diseases affect over 25 million Americans, yet less than five percent of the 7,000 […]
SOUTH SAN FRANCISCO, Calif.– Fluxion Biosciences, Inc. announced today that it has registered its South San Francisco facility as a medical device establishment with the U.S. Food and Drug Administration. The company plans to use this facility to manufacture and distribute its IsoFlux System for circulating tumor cell analysis, which will be launched in November. […]
Baltimore, MD and Cambridge, UK – BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Lab21, a global leader in personalized healthcare diagnostics, announced today that they will collaborate to develop oncology assays for the BD MAX™ fully automated, bench-top molecular system. Under the terms of the […]
VIENNA, Austria – Bio-IT World Europe Conference – GenoLogics Life Sciences Software, a leading provider of laboratory information management systems (LIMS) designed for today’s omics labs, unveiled Clarity LIMS, a revolutionary LIMS that sets the bar for LIMS in clinical and research environments. Specifically designed for sequencing, Clarity LIMS is an intuitive lab management system […]
CARLSBAD, Calif. and SINGAPORE, — Life Technologies Corporation (NASDAQ: LIFE) and VelaDx have entered into a license and supply agreement that will give VelaDx rights to develop and market next generation sequencing-based, in vitro diagnostic tests on the Ion Personal Genome Machine™ (PGM™) platform. VelaDx will seek approvals from global regulatory authorities for clinical diagnostic […]
CARLSBAD, Calif., — Life Technologies (NASDAQ: LIFE) today announced the acquisition of Compendia Bioscience, a preeminent cancer bioinformatics company widely used by the pharmaceutical industry to identify novel gene targets for drug discovery and development. Its deep oncology expertise and high-value, proprietary assets enhance Life’s diagnostic development capabilities across multiple platforms, including next-generation sequencing, qPCR […]
SANTA CLARA, Calif.– Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of approximately $18 million from the eBioscience business. The Company expects to report cash-on-hand of approximately $39.6 million as of September 30, 2012, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
